OXY

OCCIDENTAL PETROLEUM CORP /DE/
7 filings tracked
energyoil gas explorationLARGE ($10B-200B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Occidental Petroleum has executed a transformative corporate reset in the first quarter of 2026, headlined by the $9.5 billion sale of OxyChem to Berkshire Hathaway.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline-grabbing OxyChem sale, a deeper dive into the Q1 2026 filing reveals troubling trends in Occidental's core operations.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every OXY filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 report presents a company in the midst of a high-stakes transition. On one hand, the massive liquidity event from the OxyChem sale provides a critical lifeline, slashing debt and providing the cash necessary to stabilize the balance sheet. On the other hand, the underlying operational metrics show a marked decline in cash flow and continuing-operations earnings, highlighting the volatility of the energy market and the pressure of high fixed costs. For investors, the central tension lies in whether the one-time windfall from the divestiture is sufficient to bridge the gap until the core business recovers. While the path to $10 billion in debt is clearer, the shrinking operating cash flow may delay the return of capital to shareholders via buybacks. The overall impact of the filing is a significant reduction in financial risk through debt repayment, tempered by a sobering look at the current headwinds facing the company's primary oil and gas assets.

Selected Quarter

Core Takeaway

OXY has successfully traded a business unit for a significantly lower debt load, but must now prove its core energy operations can generate sustainable cash without the chemical segment.

Investor Lens

The trade-off is between the immediate security of a cleaner balance sheet and the long-term concern over declining operational cash conversion.

Watch Next

Progress toward the $10 billion principal debt target and Q2 operating cash flow from continuing operations.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.10Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 5

Repaid $6.7 billion of debt following the $9.5 billion OxyChem divestiture.

debt restructure
90%
bearishMay 5

Operating cash flow from continuing operations decreased 40% year-over-year.

margin compression
70%
bullishMay 5

Completed sale of OxyChem to Berkshire Hathaway for $9.5 billion.

divestiture
80%
bearishMay 5

Continuing operations income fell 70% YoY, excluding one-time gains.

earnings miss
60%
bullishMay 5

Repaid $6.7 billion of debt following the $9.5 billion OxyChem divestiture.

debt restructure
90%
bearishMay 5

Operating cash flow from continuing operations decreased 40% year-over-year.

margin compression
70%
bullishMay 5

Completed sale of OxyChem to Berkshire Hathaway for $9.5 billion.

divestiture
80%
bearishMay 5

Continuing operations income fell 70% YoY, excluding one-time gains.

earnings miss
60%
bullishMay 5

Repaid $6.7 billion of debt following the $9.5 billion OxyChem divestiture.

debt restructure
90%
bearishMay 5

Operating cash flow from continuing operations decreased 40% year-over-year.

margin compression
70%
bullishMay 5

Completed sale of OxyChem to Berkshire Hathaway for $9.5 billion.

divestiture
80%
bearishMay 5

Continuing operations income fell 70% YoY, excluding one-time gains.

earnings miss
60%
bullishMay 5

Repaid $6.7 billion of debt following the $9.5 billion OxyChem divestiture.

debt restructure
90%
bearishMay 5

Operating cash flow from continuing operations decreased 40% year-over-year.

margin compression
70%
bullishMay 5

Completed sale of OxyChem to Berkshire Hathaway for $9.5 billion.

divestiture
80%
bearishMay 5

Continuing operations income fell 70% YoY, excluding one-time gains.

earnings miss
60%
bullishMay 5

Repaid $6.7 billion of debt following the $9.5 billion OxyChem divestiture.

debt restructure
90%
bearishMay 5

Operating cash flow from continuing operations decreased 40% year-over-year.

margin compression
70%
bullishMay 5

Completed sale of OxyChem to Berkshire Hathaway for $9.5 billion.

divestiture
80%
bearishMay 5

Continuing operations income fell 70% YoY, excluding one-time gains.

earnings miss
60%
bullishMay 5

Repaid $6.7 billion of debt following the $9.5 billion OxyChem divestiture.

debt restructure
90%
bearishMay 5

Operating cash flow from continuing operations decreased 40% year-over-year.

margin compression
70%
bullishMay 5

Completed sale of OxyChem to Berkshire Hathaway for $9.5 billion.

divestiture
80%
bearishMay 5

Continuing operations income fell 70% YoY, excluding one-time gains.

earnings miss
60%
bullishMay 5

Repaid $6.7 billion of debt following the $9.5 billion OxyChem divestiture.

debt restructure
90%
bearishMay 5

Operating cash flow from continuing operations decreased 40% year-over-year.

margin compression
70%
bullishMay 5

Completed sale of OxyChem to Berkshire Hathaway for $9.5 billion.

divestiture
80%
bearishMay 5

Continuing operations income fell 70% YoY, excluding one-time gains.

earnings miss
60%

Filing History

10-QMay 5, 2026
Expand Sequence

The Q1 2026 report presents a company in the midst of a high-stakes transition. On one hand, the massive liquidity event from the OxyChem sale provides a critical lifeline, slashing debt and providing the cash necessary to stabilize the balance sheet. On the other hand, the underlying operational metrics show a marked decline in cash flow and continuing-operations earnings, highlighting the volatility of the energy market and the pressure of high fixed costs. For investors, the central tension lies in whether the one-time windfall from the divestiture is sufficient to bridge the gap until the core business recovers. While the path to $10 billion in debt is clearer, the shrinking operating cash flow may delay the return of capital to shareholders via buybacks. The overall impact of the filing is a significant reduction in financial risk through debt repayment, tempered by a sobering look at the current headwinds facing the company's primary oil and gas assets.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.